National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

inalimarev (IN-uh-LIM-uh-rev)

 A cancer vaccine made with a form of vaccinia virus that does not cause disease in humans. It is being studied in the treatment of some types of cancer. The virus is changed in the laboratory to make human proteins, including the tumor markers called CEA and MUC-1, that may help immune cells in the body kill tumor cells. Also called PANVAC-V and recombinant vaccinia-CEA-MUC-1-TRICOM vaccine.



Previous Definitions:in situ, in vitro, in vitro fertilization, in vivo, in-transit metastasis
Next Definitions:incidence, incision, incisional biopsy, incomplete Freund's adjuvant, incontinence

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov